130 related articles for article (PubMed ID: 36734846)
1. Synthesis and Biophysical Properties of Phosphorodiamidate Piperidino Oligomers.
Ghosh A; Akabane-Nakata M; Kundu J; Harp JM; Madaoui M; Egli M; Manoharan M; Sinha S
Org Lett; 2023 Feb; 25(6):901-906. PubMed ID: 36734846
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of Morpholino Monomers, Chlorophosphoramidate Monomers, and Solid-Phase Synthesis of Short Morpholino Oligomers.
Bhadra J; Pattanayak S; Sinha S
Curr Protoc Nucleic Acid Chem; 2015 Sep; 62():4.65.1-4.65.26. PubMed ID: 26380905
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Validation of Phosphorodiamidate Morpholino Oligomers.
Aung-Htut MT; McIntosh CS; West KA; Fletcher S; Wilton SD
Molecules; 2019 Aug; 24(16):. PubMed ID: 31408997
[TBL] [Abstract][Full Text] [Related]
4. Variations in amino acid composition of antisense peptide-phosphorodiamidate morpholino oligomer affect potency against Escherichia coli in vitro and in vivo.
Mellbye BL; Puckett SE; Tilley LD; Iversen PL; Geller BL
Antimicrob Agents Chemother; 2009 Feb; 53(2):525-30. PubMed ID: 19015356
[TBL] [Abstract][Full Text] [Related]
5. Antisense oligonucleotides: absorption, distribution, metabolism, and excretion.
Shadid M; Badawi M; Abulrob A
Expert Opin Drug Metab Toxicol; 2021 Nov; 17(11):1281-1292. PubMed ID: 34643122
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 5'-Thiol Functionalized Morpholino Oligo-Nucleotide and Subsequent Conjugation with IGT to Improve Delivery and Antisense Efficacy
Ghosh U; Gupta S; Sinha S
Bioconjug Chem; 2023 Jan; 34(1):174-180. PubMed ID: 36538654
[TBL] [Abstract][Full Text] [Related]
7. Understanding Antisense Oligonucleotide Efficiency in Inhibiting Prokaryotic Gene Expression.
Story S; Bhaduri S; Ganguly S; Dakarapu R; Wicks SL; Bhadra J; Kwange S; Arya DP
ACS Infect Dis; 2024 Mar; 10(3):971-987. PubMed ID: 38385613
[TBL] [Abstract][Full Text] [Related]
8. C5-pyrimidine-functionalized morpholino oligonucleotides exhibit differential binding affinity, target specificity and lipophilicity.
Das A; Ghosh A; Sinha S
Org Biomol Chem; 2023 Feb; 21(6):1242-1253. PubMed ID: 36633261
[TBL] [Abstract][Full Text] [Related]
9. Helix-Stabilized Cell-Penetrating Peptides for Delivery of Antisense Morpholino Oligomers: Relationships among Helicity, Cellular Uptake, and Antisense Activity.
Takada H; Tsuchiya K; Demizu Y
Bioconjug Chem; 2022 Jul; 33(7):1311-1318. PubMed ID: 35737901
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of Backbone-Modified Morpholino Oligonucleotides Using Phosphoramidite Chemistry.
Paul S; Caruthers MH
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513252
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Biophysical Studies of High-Affinity Morpholino Oligomers Containing G-Clamp Analogs.
Das A; Ghosh A; Kundu J; Egli M; Manoharan M; Sinha S
J Org Chem; 2023 Nov; 88(21):15168-15175. PubMed ID: 37843026
[TBL] [Abstract][Full Text] [Related]
12. Sequencing of Morpholino Antisense Oligonucleotides Using Electron Capture Dissociation Mass Spectrometry.
Karasawa K; Duchoslav E; Burton L; Kawakami J; Baba T
Anal Chem; 2023 Nov; 95(44):16352-16358. PubMed ID: 37871344
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of Phosphorodiamidate Morpholino Oligonucleotides and Their Chimeras Using Phosphoramidite Chemistry.
Paul S; Caruthers MH
J Am Chem Soc; 2016 Dec; 138(48):15663-15672. PubMed ID: 27934012
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor down-regulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers.
Ko YJ; Devi GR; London CA; Kayas A; Reddy MT; Iversen PL; Bubley GJ; Balk SP
J Urol; 2004 Sep; 172(3):1140-4. PubMed ID: 15311058
[TBL] [Abstract][Full Text] [Related]
15. Aggregation and Disaggregation of Morpholino Oligomers in Solution.
Chow G; Morcos PA; Moulton HM
Methods Mol Biol; 2017; 1565():31-38. PubMed ID: 28364231
[TBL] [Abstract][Full Text] [Related]
16. Delivery of phosphorodiamidate morpholino antisense oligomers in cancer cells.
Devi GR
Methods Mol Biol; 2009; 542():351-61. PubMed ID: 19565912
[TBL] [Abstract][Full Text] [Related]
17. Bubble liposomes and ultrasound exposure improve localized morpholino oligomer delivery into the skeletal muscles of dystrophic mdx mice.
Negishi Y; Ishii Y; Shiono H; Akiyama S; Sekine S; Kojima T; Mayama S; Kikuchi T; Hamano N; Endo-Takahashi Y; Suzuki R; Maruyama K; Aramaki Y
Mol Pharm; 2014 Mar; 11(3):1053-61. PubMed ID: 24433046
[TBL] [Abstract][Full Text] [Related]
18. Fully automated fast-flow synthesis of antisense phosphorodiamidate morpholino oligomers.
Li C; Callahan AJ; Simon MD; Totaro KA; Mijalis AJ; Phadke KS; Zhang G; Hartrampf N; Schissel CK; Zhou M; Zong H; Hanson GJ; Loas A; Pohl NLB; Verhoeven DE; Pentelute BL
Nat Commun; 2021 Jul; 12(1):4396. PubMed ID: 34285203
[TBL] [Abstract][Full Text] [Related]
19. Convergent synthesis of phosphorodiamidate morpholino oligonucleotides (PMOs) by the H-phosphonate approach.
Tsurusaki T; Sato K; Imai H; Hirai K; Takahashi D; Wada T
Sci Rep; 2023 Aug; 13(1):12576. PubMed ID: 37537221
[TBL] [Abstract][Full Text] [Related]
20. Construction of nanostructured DNA harbouring phosphorodiamidate morpholino oligonucleotide for controlled tissue distribution in mice.
Takahashi Y; Araie Y; Nomura D; Takahashi Y; Sano K; Saji H; Takakura Y; Nishikawa M
J Drug Target; 2018 Apr; 26(4):373-381. PubMed ID: 28972806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
